Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers

Taubel, J; Lorch, U; Spencer, CS; Freier, A; Camilleri, D; Djumanov, D; Ferber, G; Marchand, L; Gotteland, JP; Pohl, O

Taubel, J (corresponding author), St Georges Univ London, Richmond Pharmacol Ltd, Cranmer Terrace, London SW17 0RE, England.; Taubel, J (corresponding author), St Georges Univ London, Cardiovasc & Cell Sci Res Inst, London, England.

SCIENTIFIC REPORTS, 2021; 11 (1):

Abstract

Nolasiban is an orally active oxytocin receptor antagonist being developed to increase the efficiency of assisted reproductive technologies. This stud......

Full Text Link